Overview
Background
Dr Zara Ioannides is a senior lecturer at The University of Queensland and consultant neurologist at the Royal Brisbane and Women’s Hospital. Dr Ioannides has been a member of the multiple sclerosis (MS) research team since 2014 and group leader since 2020.
Dr Ioannides graduated from Imperial College, University of London in 2006 with first class honours in a Bachelor of Science degree and a distinction in a Bachelor of Medicine and Bachelor of Surgery. After completing physician training in Australia, Dr Ioannides qualified as a clinical neurologist in 2014 and attained a Master of Philosophy in neuroscience in 2018.
Dr Ioannides is a neurologist in the MS clinic at the Royal Brisbane and Women’s hospital and a principal investigator in clinical research involving EBV-specific T cell therapy in MS. Her current research focuses on the roles of autoimmunity and EBV infection in the pathogenesis of MS and on novel treatments of MS.
Dr Ioannides is passionate about supporting people living with neurological diseases through research and clinical avenues.
Availability
- Dr Zara Ioannides is:
- Available for supervision
Works
Search Professor Zara Ioannides’s works on UQ eSpace
2021
Journal Article
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
Ioannides, Zara A., Csurhes, Peter A., Douglas, Nanette L., Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M., Hopkins, Tracey J., Green, Kerryn A., Blum, Stefan, Hooper, Kaye D., Wyssusek, Kerstin H., Coulthard, Alan and Pender, Michael P. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy. Frontiers in Neurology, 12 652811, 652811. doi: 10.3389/fneur.2021.652811
2021
Journal Article
Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis
Ioannides, Zara A., Csurhes, Peter A., Swayne, Andrew, Foubert, Philippe, Aftab, Blake T. and Pender, Michael P. (2021). Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis. Multiple Sclerosis Journal Experimental, Translational and Clinical, 7 (2), 1-12. doi: 10.1177/20552173211019772
2020
Journal Article
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2020). Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight, 5 (20) e144624. doi: 10.1172/jci.insight.144624
2018
Journal Article
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714
2018
Journal Article
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Steyn, Frederik J., Ioannides, Zara A., van Eijk, Ruben P. A., Heggie, Susan, Thorpe, Kathryn A., Ceslis, Amelia, Heshmat, Saman, Henders, Anjali K., Wray, Naomi R., van den Berg, Leonard H., Henderson, Robert D., McCombe, Pamela A. and Ngo, Shyuan T. (2018). Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Journal of Neurology, Neurosurgery, and Psychiatry, 89 (10), jnnp-2017. doi: 10.1136/jnnp-2017-317887
2017
Journal Article
The utility of FDG-PET in complex neurological conditions
Ioannides, Zara A., Thomas, Paul, Langguth, Daman, Kubler, Paul and Henderson, Robert D. (2017). The utility of FDG-PET in complex neurological conditions. Internal Medicine Journal, 47 (12), 1460-1462. doi: 10.1111/imj.13638
2017
Other Outputs
Energy metabolism in amyotrophic lateral sclerosis: assessment of body composition and energy expenditure
Ioannides, Zara Amina (2017). Energy metabolism in amyotrophic lateral sclerosis: assessment of body composition and energy expenditure. MPhil Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/uql.2017.829
2017
Journal Article
Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass
Ioannides, Z. A., Steyn, F. J., Henderson, R. D., McCombe, P. A. and Ngo, S. T. (2017). Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass. Cogent Medicine, 4 (1), 1343000. doi: 10.1080/2331205X.2017.1343000
2017
Journal Article
Anthropometric measures are not accurate predictors of fat mass in ALS
Ioannides, Zara A., Steyn, Frederik J., Henderson, Robert D., Mccombe, Pamela A. and Ngo, Shyuan T. (2017). Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18 (7-8), 486-491. doi: 10.1080/21678421.2017.1317811
2016
Journal Article
Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression
Ioannides, Z. A., Ngo, S. T., Henderson, R. D., McCombe, P. A. and Steyn, F. J. (2016). Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegenerative Diseases, 15 (5-6), 382-397. doi: 10.1159/000446502
2015
Journal Article
Neurological disorders that may deteriorate with intensive physical rehabilitation
Ioannides, Z. A., McGill, J., Robertson, T. and Henderson, R. D. (2015). Neurological disorders that may deteriorate with intensive physical rehabilitation. Internal Medicine Journal, 45 (11), 1193-1195. doi: 10.1111/imj.12903
2015
Journal Article
When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms
Ioannides, Z. A., Henderson, R. D., Robertson, T., Davis, M. and McCombe, P. A. (2015). When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms. Journal of Neurology, Neurosurgery and Psychiatry, 87 (9), 1031-1032. doi: 10.1136/jnnp-2015-311582
Supervision
Availability
- Dr Zara Ioannides is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Zara Ioannides's areas of expertise, story ideas and help finding experts, contact our Media team: